The biotechnology industry uses advances in genetics research to develop products for human diseases and conditions. This section includes news on pharmaceutical companies, mergers and acquisitions, drug development, export and import of drugs, legislation, advertising and influence.
Could blocking these proteins stop breast cancer?
A study suggests that blocking certain epigenetic proteins with drugs could prevent women at high risk of breast cancer from developing the disease.
Type 2 diabetes: New pill could 'mimic the effects of surgery'
A material that temporarily coats the small intestine and can be taken in pill form before a meal reduced glucose response by 47 percent in rats.
This 'light-activated' drug could treat Parkinson's
A drug activated in the brain using light delivered by implanted optical fiber improved motor function and reduced Parkinson's symptoms in mice.
Atherosclerosis: Could there be a best time of day for medication?
New research finds that the biological processes of atherosclerosis vary according to time of day and may have implications for timing of medication.
One shot may block chemo pain for several weeks
One injection of a protein into the spines of mice reversed pain states induced by chemotherapy for 2 months by altering pain processes in cells.
Could Viagra and a flu shot kill cancer?
A Viagra, Cialis, and inactivated flu vaccine combination reduced cancer spread in a mouse model of post-surgery metastasis by helping the immune system.
This 'metastasis-blocking' compound may stop the spread of cancer
A compound that targets a unique structure in cancer cell nuclei and has links to metastasis potential stopped cancer spread and extended survival in mice.
Cancer: New drug may fight treatment resistance
A new drug that blocks a molecule that cancer cells rely on for transcribing genetic information shows promise in tackling treatment-resistant tumors.
'Natural insecticide' kills advanced prostate cancer cells
Scientists identify a class of drugs that selectively targets and kills advanced prostate cancer cells that lack the tumor-suppressor protein PTEN.
Prostate cancer: How a full stomach could improve treatment
A new study finds that the prostate cancer drug Zytiga is more effective, as well as cheaper, when taken with food, as opposed to on an empty stomach.
Alzheimer's: This antibody may halt brain injury
A study shows how an antibody that targets the APOE protein halved brain levels of plaque in mice with Alzheimer's disease without harming APOE in the blood.
Many non-antibiotic drugs can alter gut bacteria
A new study reveals that many marketed non-antibiotic drugs affect the growth of bacteria in the human gut and may contribute to antibiotic resistance.
Targeting these brain cells may aid weight loss
Scientists may have found a new obesity treatment, after exploring mice's 'feed or flee' responses and finding that they could target the 'control switch.'
How an existing diabetes drug controls pancreatic cancer
A new study suggests that targeting the RET signaling pathway with metformin might offer a new way to stop the growth and spread of pancreatic cancer.
New drug could reduce hot flashes 'by 72 percent'
Fresh analysis of trial data finds that a new class of drug rapidly reduces severity and frequency of hot flashes and other symptoms in menopausal women.
Autism: Anti-cancer drug may improve social behavior
Romidepsin, a compound that is already approved for treating cancer, reversed social deficits in a mouse model of autism by restoring gene expression.
VMS has experienced more than two decades of success by strategically partnering with our clients to continually provide best-in-class service. We have been recognized for our key contributions and impressive growth.
For the third consecutive year, rated a Great Place to Work® by the experts who produce FORTUNE's 100 Best Companies to Work For® list